Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Ershova, Anna; Gra, Olga; Lyaschuk, Alexander; Grunina, Tatyana; Tkachuk, Artem; Bartov, Mikhail; Savina, Darya; Sergienko, Olga; Galushkina, Zoya; Gudov, Vladimir; Kozlovskaya, Liubov; Kholodilov, Ivan; Gmyl, Larissa; Karganova, Galina; Lunin, Vladimir; Karyagina, Anna; Gintsburg, Alexander
• Is Part Of: BMC infectious diseases. Volume 16:Issue 1(2016)
• Page Start: 1
• Page End: 11
• Publication Date: 2016-12
• Subjects: Tick-borne encephalitis virus -- Envelope protein -- Domain III -- Dextran-binding domain -- CpG oligonucleotides; Communicable diseases -- Periodicals; Sexually Transmitted Diseases -- Periodicals; 616.905
• DOI: 10.1186/s12879-016-1884-5
• Languages: English
• ISSNs: 1471-2334

Abstract

Abstract Background E protein of tick-borne encephalitis virus (TBEV) and other flaviviruses is located on the surface of the viral particle. Domain III of this protein seems to be a promising component of subunit vaccines for prophylaxis of TBE and kits for diagnostics of TBEV. Methods Three variants of recombinant TBEV E protein domain III of European, Siberian and Far Eastern subtypes fused with dextran-binding domain ofLeuconostoc citreum KM20 were expressed inE. coli and purified. The native structure of domain III was confirmed by ELISA antibody kit and sera of patients with tick-borne encephalitis. Immunogenic and protective properties of the preparation comprising these recombinant proteins immobilized on a dextran carrier with CpG oligonucleotides as an adjuvant were investigated on the mice model. Results All 3 variants of recombinant proteins immobilized on dextran demonstrate specific interaction with antibodies from the sera of TBE patients. Thus, constructed recombinant proteins seem to be promising for TBE diagnostics. The formulation comprising the 3 variants of recombinant antigens immobilized on dextran and CpG oligonucleotides, induces the production of neutralizing antibodies against TBEV of different subtypes and demonstrates partial protectivity against TBEV infection. Conclusions Studied proteins interact with the sera of TBE patients, and, in combination with dextran and CPGs, demonstrate immunogenicity and limited protectivity on mice compared with reference "Tick-E-Vac" vaccine.